Pharmaceutical Industry Research Report, Pharma Market

sale

Recombinant Coagulation Factors Market

U

2026

Recombinant Coagulation Factors Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.

Report Code : A02925 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Recombinant Chinese Hamster Ovary Cell (CHO) Hepatitis B...

U

2026

Recombinant Chinese Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is ...

Report Code : A03515 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Recombinant Vaccines Market

P

2022

Recombinant Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global recombinant vaccines market was valued at $8.1 billion in 2021, and is projected to reach $24.7 billion by 2031, growing at a CAGR of 11.4% from 2022 to 2031.

Report Code : A17605 | Pages : 258 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Whole Cell Cholera Vaccine by End User

U

2026

Whole Cell Cholera Vaccine by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Cholera is a chronic disease associated with diarrhea and immediate treatment is essential as death is inevitable if the disease is left untreated. Cholera is an acute infection ...

Report Code : A03456 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Human Recombinant Insulin Market

P

2024

Human Recombinant Insulin Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global human recombinant insulin market was valued at $27.6 billion in 2023, and is projected to reach $34.7 billion by 2033, growing at a CAGR of 2.4% from 2024 to 2033.

Report Code : A281792 | Pages : 300 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Pharmaceuticals

Filter by Region

Filter by Discounts

Filter by Category

Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.

Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is ...

The global recombinant vaccines market was valued at $8.1 billion in 2021, and is projected to reach $24.7 billion by 2031, growing at a CAGR of 11.4% from 2022 to 2031.

Cholera is a chronic disease associated with diarrhea and immediate treatment is essential as death is inevitable if the disease is left untreated. Cholera is an acute infection ...

The global human recombinant insulin market was valued at $27.6 billion in 2023, and is projected to reach $34.7 billion by 2033, growing at a CAGR of 2.4% from 2024 to 2033.